Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
10.42T | 8.42T | 7.86T | 7.53T | 6.31T | Gross Profit |
10.34T | 8.42T | 7.86T | 7.53T | 6.31T | EBIT |
0.00 | 140.46B | 357.70B | 375.75B | -7.36B | EBITDA |
565.73B | 395.02B | 591.04B | 589.33B | 209.89B | Net Income Common Stockholders |
320.76B | 173.74B | 409.35B | 363.78B | 32.43B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.06T | 1.62T | 2.18T | 1.88T | 1.21T | Total Assets |
67.54T | 61.58T | 65.88T | 63.59T | 60.01T | Total Debt |
975.29B | 949.67B | 870.38B | 899.77B | 1.14T | Net Debt |
-1.09T | -669.41B | -1.31T | -984.37B | -70.17B | Total Liabilities |
63.66T | 58.71T | 61.47T | 58.79T | 56.24T | Stockholders Equity |
3.88T | 2.87T | 4.41T | 4.81T | 3.78T |
Cash Flow | Free Cash Flow | |||
904.23B | -294.15B | -611.09B | -156.38B | 510.63B | Operating Cash Flow |
997.38B | -132.47B | -462.08B | -79.90B | 590.08B | Investing Cash Flow |
-601.65B | 310.44B | 963.28B | 551.36B | -896.44B | Financing Cash Flow |
-145.76B | -325.45B | -180.71B | 65.59B | 784.87B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $10.78T | 10.30 | 22.63% | 2.55% | 14.87% | 74.60% | |
72 Outperform | ¥4.56T | 9.61 | 17.07% | 2.69% | 11.37% | 27.90% | |
67 Neutral | $5.17T | 7.17 | 17.38% | 2.93% | -1.15% | 104.17% | |
64 Neutral | ¥3.82T | 8.48 | 13.11% | 3.03% | 2.99% | 81.04% | |
64 Neutral | $12.57B | 9.74 | 7.88% | 16985.68% | 12.42% | -5.45% | |
59 Neutral | ¥1.05T | 10.16 | 3.68% | 23.94% | 22.80% |
Dai-ichi Life Holdings has announced the completion of the first phase of a significant reinsurance transaction involving its subsidiary, Protective Life Corporation. This transaction involves ceding approximately 65% of a targeted USD 9.7 billion block of insurance policies, which is expected to increase the company’s total consolidated assets by over 30%. The transaction is progressing as planned, with further developments anticipated following the establishment of a captive entity, although it will not impact the company’s financial results for the fiscal year ending March 31, 2025.
Dai-ichi Life Holdings has completed the payment related to the issuance of 2,000 new shares under its stock remuneration scheme, as approved by its Board of Directors. This move is part of the company’s strategy to align executive compensation with performance, potentially impacting its operational dynamics and stakeholder interests.
Dai-ichi Life Holdings and Marubeni Corporation have announced a business consolidation agreement to merge their domestic real estate operations. This strategic move aims to create a robust real estate value chain by integrating development, ownership, leasing, and property management businesses. The collaboration is expected to enhance operational efficiency, create new value, and strengthen the revenue base for both companies, positioning them as leading players in Japan’s real estate asset management sector.
Dai-ichi Life Holdings, Inc. announced a resolution to issue 2,000 new shares under a stock remuneration scheme aimed at aligning the interests of eligible directors and shareholders. This initiative, part of a broader strategy including a performance-linked stock compensation plan, is designed to incentivize directors, foster corporate growth, and enhance shareholder value.
Dai-ichi Life Holdings announced an expansion of its shareholder benefit program to increase the attractiveness of its shares and encourage long-term holding. The revised program enhances the healthcare app ‘QOLism’ and the ‘Benefit Station’ lifestyle service, offering increased points and incentives for new and existing shareholders, thus potentially strengthening shareholder engagement and satisfaction.
Dai-ichi Life Holdings has announced a stock split, aiming to lower the minimum investment unit to attract more investors and broaden its shareholder base. The split will see each existing share divided into four, increasing the total number of shares substantially, with no immediate impact on the company’s capital or year-end dividend policy.
Dai-ichi Life Holdings announced that it will change its trade name to Daiichi Life Group, Inc., effective April 1, 2026, to better reflect its expanded business focus beyond traditional life insurance. This rebranding aims to enhance the group’s unity, accelerate growth, and solidify its position as a top-tier global insurance group, while also emphasizing a broader commitment to opening up possibilities for people’s lives.
Dai-ichi Life Holdings has revised its consolidated earnings and dividend forecasts for the fiscal year ending March 31, 2025. The company expects an increase in ordinary revenues, profits, and dividends due to higher investment income and reduced amortization of intangible assets. This revision reflects a positive outlook for the company’s financial performance, potentially benefiting stakeholders through increased dividends and signaling strong operational efficiencies.
Neo First Life Insurance Company, a subsidiary of Dai-ichi Life Holdings, reported its financial results for the nine months ending December 31, 2024. The announcement includes detailed financial and investment results, providing insights into the company’s performance and financial health, which are crucial for stakeholders to understand its market position and future prospects.
The Dai-ichi Frontier Life Insurance Co., Ltd., a subsidiary of Dai-ichi Life Holdings, has released its financial results for the nine months ending December 31, 2024. The announcement highlights the company’s financial performance and provides detailed insights into its investment results, balance sheet, and solvency margin ratio, offering stakeholders a comprehensive view of its operational stability and financial health.
The Dai-ichi Life Insurance Company, Limited announced its financial results for the nine months ending December 31, 2024, highlighting the company’s business performance and financial standing. The report covers key areas such as business highlights, investment results, and financial summaries, reflecting its operational health and market positioning.
Dai-ichi Life Holdings reported a significant increase in net income of 62.3% for the nine months ended December 31, 2024, reflecting a strong operational performance compared to the previous year. The company has revised its dividend forecasts and consolidated earnings projections for the fiscal year ending March 31, 2025, indicating a strategic adjustment to sustain its financial robustness and shareholder value.
Dai-ichi Life Holdings addressed media reports about a potential name change to ‘Daiichi Life Group’ and an expected extraordinary loss of nearly 30 billion yen due to the ‘Second Career Special Support Framework.’ The company confirmed these matters are under consideration and will discuss them at a Board of Directors meeting, promising timely disclosures if necessary.
Dai-ichi Life Holdings, Inc. has announced its decision to acquire 6.91% of IRRC Corporation’s shares from its subsidiary, Neo First Life Insurance Co., Ltd. This strategic move involves the acquisition of 566,800 shares, and it is significant as it constitutes an act of buying up specified by Japanese financial regulations, indicating a potential impact on the company’s market positioning and stakeholder interests.